Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-02-01

FDA Approved: CATAPRES-TTS-1 — Supplemental Application (Technomed Inc.)

View source ↗

Summary

FDA approved a supplemental application for CATAPRES-TTS-1 (clonidine transdermal system) by Technomed Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CATAPRES-TTS-1 (Clonidine transdermal system)

Snippet

SUPPL AP for CATAPRES-TTS-1 (CLONIDINE TRANSDERMAL SYSTEM)